Impact of circulating microRNA test (miRNA‐371a‐3p) on appropriateness of treatment and cost outcomes in patients with Stage I non‐seminomatous germ cell tumours
BJU international, 2021-07, Vol.128 (1), p.57-64 [Peer Reviewed Journal]2020 The Authors BJU International © 2020 BJU International ;BJUI © 2021 BJU International ;ISSN: 1464-4096 ;EISSN: 1464-410X ;DOI: 10.1111/bju.15288
Full text available